Using a Sequential Regimen to Eliminate Bacteria at Sublethal Antibiotic Dosages

Genomics of Rapid Adaptation to Antibiotics: Convergent Evolution and Scalable Sequence Amplification

(2014) David Laehnemann et al.   Genome Biology and Evolution

Strength of Selection Pressure Is an Important Parameter Contributing to the Complexity of Antibiotic Resistance Evolution

(2014) Tugce Oz et al.   MOLECULAR BIOLOGY AND EVOLUTION

Alternating antibiotic treatments constrain evolutionary paths to multidrug resistance

(2014) Seungsoo Kim et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

When the Most Potent Combination of Antibiotics Selects for the Greatest Bacterial Load: The Smile-Frown Transition

(2014) Rafael Pena-Miller et al.   PLOS BIOLOGY

Cecum Lymph Node Dendritic Cells Harbor Slow-Growing Bacteria Phenotypically Tolerant to Antibiotic Treatment

(2014) Patrick Kaiser et al.   PLOS BIOLOGY

Antibiotics and Staphylococcus aureus—more than meets the MIC

(2013) Benjamin P. Howden   JOURNAL OF MOLECULAR MEDICINE-JMM

Nafcillin enhances innate immune-mediated killing of methicillin-resistant Staphylococcus aureus

(2013) George Sakoulas et al.   JOURNAL OF MOLECULAR MEDICINE-JMM

Bacterial evolution of antibiotic hypersensitivity

(2013) V. Lazar et al.   Molecular Systems Biology

Immune modulation by multifaceted cationic host defense (antimicrobial) peptides

(2013) Ashley L Hilchie et al.   Nature Chemical Biology

Use of Collateral Sensitivity Networks to Design Drug Cycling Protocols That Avoid Resistance Development

(2013) L. Imamovic et al.   Science Translational Medicine

A Moonlighting Enzyme Links Escherichia coli Cell Size with Central Metabolism

(2013) Norbert S. Hill et al.   PLoS Genetics

Aggressive Chemotherapy and the Selection of Drug Resistant Pathogens

(2013) Silvie Huijben et al.   PLoS Pathogens

Dosing Regimen Matters: the Importance of Early Intervention and Rapid Attainment of the Pharmacokinetic/Pharmacodynamic Target

(2012) Marilyn N. Martinez et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Collateral sensitivity as a strategy against cancer multidrug resistance

(2012) Kristen M. Pluchino et al.   DRUG RESISTANCE UPDATES

Randomised clinical trial: the efficacy of a 10-day sequential therapy vs. a 14-day standard proton pump inhibitor-based triple therapy for Helicobacter pylori in Korea

(2011) Y. S. Kim et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Combination therapies for combating antimicrobial resistance

(2011) Michael A Fischbach   CURRENT OPINION IN MICROBIOLOGY

14-day triple, 5-day concomitant, and 10-day sequential therapies for Helicobacter pylori infection in seven Latin American sites: a randomised trial

(2011) E Robert Greenberg et al.   LANCET

Selection of Resistant Bacteria at Very Low Antibiotic Concentrations

(2011) Erik Gullberg et al.   PLoS Pathogens

Impact of Burden on Granulocyte Clearance of Bacteria in a Mouse Thigh Infection Model

(2010) G. L. Drusano et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Origins and Evolution of Antibiotic Resistance

(2010) J. Davies et al.   MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS

Constitutive SoxS Expression in a Fluoroquinolone-Resistant Strain with a Truncated SoxR Protein and Identification of a New Member of the marA-soxS-rob Regulon, mdtG

(2009) A. Fabrega et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Vancomycin in Combination with Other Antibiotics for the Treatment of Serious Methicillin‐ResistantStaphylococcus aureusInfections

(2009) Stan Deresinski   CLINICAL INFECTIOUS DISEASES

Antibiotic resistance—What’s dosing got to do with it?

(2009) Jason A. Roberts et al.   CRITICAL CARE MEDICINE

Efflux-Mediated Drug Resistance in Bacteria

(2009) Xian-Zhi Li et al.   DRUGS

Accelerated evolution of resistance in multidrug environments

(2008) M. Hegreness et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA